Pregled po CROSBI profilu: Zdravko Anzulović (CROSBI Profil: 25662, MBZ: 120635)

1.

Tarle, Marko; Trnski, Davor; Ružić, Boris; Spajić, Boro; Reljić, Ante; Anzulović, Zdravko; Katušić, Josip; Kraus, Ognjen; Ahel, Zaky; Kraljić, Ivo.

Neuroendocrine differentiation in subclinically detected prostate cancer and during a subsequent disease progression. // Anticancer Research / Delinassios, John (ur.).
Atena: International Institute for Anticancer Research, 2001. str. 1660-1661 (predavanje, međunarodna recenzija, sažetak, znanstveni)

2.

Tarle, Marko; Kraus, Ognjen; Kraljić, Ivo; Trnski, Davor; Anzulović, Zdravko; Katušić, Josip; Reljić, Ante; Ružić, Boris

Subclinical distinction of symptomatic BPH from prostate cancer in Finasteride treated patients. // Journal of Tumor Marker Oncology. 13(2), 1998 Sum.
Lugano, Švicarska, 1998. str. 32-33 (poster, sažetak, znanstveni)

3.

Tarle, Marko; Kraljić, Ivo; Ružić, Boris; Anzulović, Zdravko; Trnski, Davor; Katušić, Josip; Reljić, Ante; Kovačić, Ksenija.

Conversion of hormone sensitive prostate cancer to hormone resistant disease: A subclinical detection. // Anticancer research, 18 (1998), 6c; 4958-4959 (međunarodna recenzija, članak, znanstveni)

4.

Kraljić, Ivo; Katušić, Josip; Trnski, Davor; Reljić, Ante; Anzulović, Zdravko; Ružić, Boris; Tarle, Marko

5.

Kraljić, Ivo; Trnski, Davor; Reljić, Ante; Anzulović, Zdravko; Tarle, Marko

Introduction into the use of serum F/T%PSA value in distinguishing between BPH, latent and manifest prostatic adenocarcinoma // British journal of urology, 80 (1997), suppl. 2; 246-246 (međunarodna recenzija, članak, znanstveni)

6.

Ružić, Boris; Reljić, Ante; Trnski, Davor; Kraus, Ognjen; Anzulović, Zdravko; Katušić, Josip; Tarle, Marko

Multivariate analysis of serum tumor markers in prostate cancer patients treated with triptorelin and maximal androgen blockade // Acta clinica Croatica, 36 (1997), 1; 41-48 (podatak o recenziji nije dostupan, članak, stručni)